Mark Phillips
Compliance Officer bei COGNETIVITY NEUROSCIENCES LTD.
Vermögen: 10 607 $ am 31.05.2024
Aktive Positionen von Mark Phillips
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| COGNETIVITY NEUROSCIENCES LTD. | Direktor/Vorstandsmitglied | 21.12.2017 | - |
| Compliance Officer | 21.12.2017 | - | |
Cognetivity Ltd.
 Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom. | Vorsitzender | 01.01.2014 | - |
Fluorogenics Ltd.
 Fluorogenics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of New England Biolabs, Inc., Fluorogenics Ltd. is a British company that specializes in sample-to-result integrated analyzers and real-time PCR lyophilized reagents. The company is based in Salisbury, UK. The company brings extensive technical expertise to the market and offers leading performance ambient stable solutions through their ISO 13485:2016 certified facilities and ADMIX custom product service. The company was founded in 2011 by Martin Alan Lee, who has been the CEO since then. Fluorogenics was acquired by New England Biolabs, Inc. on May 10, 2021. | Direktor/Vorstandsmitglied | 01.09.2016 | - |
| Centillion Technology Ltd. | Direktor/Vorstandsmitglied | 01.01.2021 | - |
Karriereverlauf von Mark Phillips
Ehemalige bekannte Positionen von Mark Phillips
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | - | - |
| Corporate Officer/Principal | - | - |
Ausbildung von Mark Phillips
| University of Cambridge | Doctorate Degree |
| Loughborough University | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 7 |
| Kanada | 2 |
Operativ
| Director/Board Member | 3 |
| Compliance Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| COGNETIVITY NEUROSCIENCES LTD. | Health Technology |
| GSK PLC | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Cognetivity Ltd.
Cognetivity Ltd. BiotechnologyHealth Technology Cognetivity Ltd. engages in the research and experimental development on biotechnology. It focuses on the diagnosis and prognosis of dementia. Its advisory board includes leaders in artificial intelligence, medical diagnostics, old age psychiatry and neurology, cognitive analysis, and brain mapping. The company was founded by Sina Habibi and Seyed Mahdi Khaligh Razavi and is headquartered in London, the United Kingdom. | Health Technology |
Fluorogenics Ltd.
Fluorogenics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of New England Biolabs, Inc., Fluorogenics Ltd. is a British company that specializes in sample-to-result integrated analyzers and real-time PCR lyophilized reagents. The company is based in Salisbury, UK. The company brings extensive technical expertise to the market and offers leading performance ambient stable solutions through their ISO 13485:2016 certified facilities and ADMIX custom product service. The company was founded in 2011 by Martin Alan Lee, who has been the CEO since then. Fluorogenics was acquired by New England Biolabs, Inc. on May 10, 2021. | Commercial Services |
| Centillion Technology Ltd. |
- Börse
- Insiders
- Mark Phillips
- Erfahrung
